Gain Therapeutics
GANX
GANX
19 hedge funds and large institutions have $5.71M invested in Gain Therapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
14% less capital invested
Capital invested by funds: $6.65M → $5.71M (-$939K)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$293K | |
| 2 | +$139K | |
| 3 | +$107K | |
| 4 |
Two Sigma Investments
New York
|
+$106K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$103K |